Oncovista Innovative Therapies Inc (OVIT) financial statements (2021 and earlier)

Company profile

Business Address 14785 OMICRON DRIVE
SAN ANTONIO, TX 78245
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1345512
Cash and cash equivalents1345512
Prepaid expense and other current assets60
Other undisclosed current assets 51 
Total current assets:1396572
Noncurrent Assets
Property, plant and equipment 03
Total noncurrent assets: 03
TOTAL ASSETS:1396575
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,6013,1402,106
Accounts payable1,6721,266934
Accrued liabilities2,5791,8741,173
Employee-related liabilities1,341  
Interest and dividends payable8  
Debt200  
Derivative instruments and hedges, liabilities 1082
Estimated litigation liability450  
Due to related parties1,240  
Other liabilities66  
Other undisclosed current liabilities(2,581)6666
Total current liabilities:4,9763,2162,254
Noncurrent Liabilities
Liabilities, other than long-term debt700  
Estimated litigation liability700  
Total noncurrent liabilities:700  
Total liabilities:5,6763,2162,254
Stockholders' equity
Stockholders' equity attributable to parent(5,663)(3,120)(1,679)
Common stock222222
Additional paid in capital20,21720,21720,208
Accumulated deficit(25,903)(23,358)(21,909)
Total stockholders' equity:(5,663)(3,120)(1,679)
TOTAL LIABILITIES AND EQUITY:1396575

Income statement (P&L) ($ in thousands)

12/31/2014
12/31/2013
12/31/2012
Operating expenses(2,546)(1,522)(1,981)
Operating loss:(2,546)(1,522)(1,981)
Nonoperating income173353
Interest and debt expense (0)108
Net loss:(2,544)(1,450)(1,521)
Other undisclosed net income (loss) attributable to parent 0(108)
Net loss available to common stockholders, diluted:(2,544)(1,450)(1,629)

Comprehensive Income ($ in thousands)

12/31/2014
12/31/2013
12/31/2012
Net loss:(2,544)(1,450)(1,521)
Comprehensive loss, net of tax, attributable to parent:(2,544)(1,450)(1,521)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: